LUPIN PHARMACEUTICALS INC

Lobbying client · Maryland · filed 2025 to 2026

$950,830 Reported spend

16 Filings counted

2 Outside firms hired

0 Bills named

Spend is reported income plus in-house expenses across 16 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as LUPIN PHARMACEUTICALS, LUPIN PHARMACEUTICALS INC.

Who filed for this client 3

LUPIN PHARMACEUTICALS INC $478,830 In-house, the client's own filings · 6 filings
BALLARD PARTNERS $320,000 Outside firm · 5 filings
MEDSECUREAN.COM $152,000 Outside firm · 5 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $269,070 4 filings
2025 $681,760 12 filings

Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 7

SENATE 10
U.S. Trade Representative (USTR) 7
White House Office 7
Commerce, Dept of (DOC) 6
HOUSE OF REPRESENTATIVES 6
Health & Human Services, Dept of (HHS) 4
State, Dept of (DOS) 4

Recent filings 17 total

Q2 report

LUPIN PHARMACEUTICALS INC

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,766 expenses · posted Jul 24, 2026

View → Q2 report

MEDSECUREAN.COM

2nd Quarter 2026 (Apr 1 - June 30) · Senate · $54,000 income · posted Jul 13, 2026

View → Q1 report

MEDSECUREAN.COM

1st Quarter 2026 (Jan 1 - Mar 31) · Senate · $42,000 income · posted Jul 13, 2026

View → Q1 report

LUPIN PHARMACEUTICALS INC

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $92,304 expenses · posted Apr 23, 2026

View → Q4 terminationNo activity

BALLARD PARTNERS

4th Quarter 2025 (Oct 1 - Dec 31) · $80,000 income · posted Apr 20, 2026

View → Q4 report

MEDSECUREAN.COM

4th Quarter 2025 (Oct 1 - Dec 31) · Senate · $42,000 income · posted Feb 14, 2026

View → Q4 report

LUPIN PHARMACEUTICALS INC

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,766 expenses · posted Jan 20, 2026

View → Q4 reportNo activity

BALLARD PARTNERS Amended

4th Quarter 2025 (Oct 1 - Dec 31) · $80,000 income · posted Jan 14, 2026

View → Q3 report

LUPIN PHARMACEUTICALS INC

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $74,997 expenses · posted Oct 27, 2025

View → Q3 report

BALLARD PARTNERS

3rd Quarter 2025 (July 1 - Sep 30) · $80,000 income · posted Oct 16, 2025

View → Q3 report

MEDSECUREAN.COM

3rd Quarter 2025 (July 1 - Sep 30) · Senate · $14,000 income · posted Sep 22, 2025

View → Registration

MEDSECUREAN.COM

1st Quarter 2025 (Jan 1 - Mar 31) · posted Sep 21, 2025

View → Q2 report

LUPIN PHARMACEUTICALS INC

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $74,997 expenses · posted Jul 21, 2025

View → Q2 report

BALLARD PARTNERS

2nd Quarter 2025 (Apr 1 - June 30) · $80,000 income · posted Jul 16, 2025

View → Q1 report

LUPIN PHARMACEUTICALS INC

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $75,000 income · posted Apr 23, 2025

View → Q1 report

BALLARD PARTNERS

1st Quarter 2025 (Jan 1 - Mar 31) · $80,000 income · posted Apr 16, 2025

View → Registration

BALLARD PARTNERS

1st Quarter 2025 (Jan 1 - Mar 31) · posted Feb 4, 2025

View →

Foreign entities disclosed 2

LUPIN INC. United States of America named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $14,000
LUPIN LTD. India named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.